ARS Pharmaceuticals

SPRYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$611.708 M

$6.16 +10.99%

Close of 7 Aug 2026

Revenue

$84.3M

#2575 by revenue

Earnings

-$171.3M

Loss-making

Shares outstanding

99,297,307

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#194Crescent BiopharmaCBIO$625.5M
#195Nuvectis PharmaNVCT$617.4M
#196ARS PharmaceuticalsSPRY$611.7M
#197AltimmuneALT$599.0M
#198VerastemVSTM$592.3M

Where these numbers come from

Share counts and financials for ARS Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.